✦ LIBER ✦

Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial

✍ Scribed by Jean Bourhis; Christian Sire; Pierre Graff; Vincent Grégoire; Philippe Maingon; Gilles Calais; Bernard Gery; Laurent Martin; Marc Alfonsi; Patrick Desprez; Thierry Pignon; Etienne Bardet; Michel Rives; Lionel Geoffrois; Nicolas Daly-Schveitzer; Sok Sen; Claude Tuchais; Olivier Dupuis; Stéphane Guerif; Michel Lapeyre; Véronique Favrel; Marc Hamoir; Antoine Lusinchi; Stéphane Temam; Antonella Pinna; Yun Gan Tao; Pierre Blanchard; Anne Aupérin

Book ID: 117785866
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 332 KB
Volume: 13
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(11)70346-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Accelerated versus Conventional Radiothe

Accelerated versus Conventional Radiotherapy with Concomitant Chemotherapy in Locally Advanced Head and Neck Carcinomas: Results of a Phase III Randomized Trial

✍ J. Bourhis; C. Sire; M. Lapeyre; V. Grégoire; P. Maingon; G. Calais; L. Martin; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Zalutumumab plus best supportive care ve

Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial

✍ Jean-Pascal Machiels; Somasundaram Subramanian; Agnes Ruzsa; Gabor Repassy; Igor 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 315 KB